- Home
- HTGC vs LNTH Comparison
HTGC vs LNTH Comparison
Compare HTGC & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTGC
- LNTH
- Stock Information
- Founded
- HTGC 2003
- LNTH 1956
- Country
- HTGC United States
- LNTH United States
- Employees
- HTGC N/A
- LNTH N/A
- Industry
- HTGC Investment Managers
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- HTGC Finance
- LNTH Health Care
- Exchange
- HTGC Nasdaq
- LNTH Nasdaq
- Market Cap
- HTGC 3.5B
- LNTH 3.6B
- IPO Year
- HTGC 2005
- LNTH 2015
- Fundamental
- Price
- HTGC $17.73
- LNTH $52.53
- Analyst Decision
- HTGC Buy
- LNTH Strong Buy
- Analyst Count
- HTGC 8
- LNTH 6
- Target Price
- HTGC $21.31
- LNTH $85.50
- AVG Volume (30 Days)
- HTGC 982.6K
- LNTH 1.4M
- Earning Date
- HTGC 10-29-2025
- LNTH 11-05-2025
- Dividend Yield
- HTGC 10.49%
- LNTH N/A
- EPS Growth
- HTGC N/A
- LNTH N/A
- EPS
- HTGC 1.52
- LNTH 3.77
- Revenue
- HTGC $504,002,000.00
- LNTH $1,520,653,000.00
- Revenue This Year
- HTGC $9.13
- LNTH N/A
- Revenue Next Year
- HTGC $6.61
- LNTH $3.24
- P/E Ratio
- HTGC $11.82
- LNTH $13.74
- Revenue Growth
- HTGC 3.72
- LNTH 5.75
- 52 Week Low
- HTGC $15.65
- LNTH $47.25
- 52 Week High
- HTGC $22.04
- LNTH $118.21
- Technical
- Relative Strength Index (RSI)
- HTGC 32.01
- LNTH 37.44
- Support Level
- HTGC $17.80
- LNTH $49.75
- Resistance Level
- HTGC $18.81
- LNTH $53.97
- Average True Range (ATR)
- HTGC 0.31
- LNTH 1.52
- MACD
- HTGC -0.12
- LNTH 0.44
- Stochastic Oscillator
- HTGC 13.14
- LNTH 2.78
About HTGC Hercules Capital Inc.
Hercules Capital Inc is a specialty finance company that provides senior secured loans to high-growth, venture capital-backed companies in various technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries, including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.